Escape tablets 120 mg, # 40

Escape tab.

p / o captivity.

120mg No. 40

Name ENG

ESCAPE

Clinical and pharmacological group

A drug that has a protective effect on the mucous membrane of the stomach and duodenum.

ATX code

Bismuth subcitrate

Dosage

120mg

Structure

Active substance: bismuth tripotassium dicitrate - 300.00 mg, in terms of bismuth oxide - 120.00 mg Excipients: corn starch - 54.22 mg, povidone (medium molecular weight polyvinylpyrrolidone, povidone K 25) - 42.00 mg, polacrilin (potassium polacrilin) ​​- 20.00 mg, magnesium stearate - 3.78 mg.

.Shell: AquaPolish® P white 019.49 MS [Hydroxypropyl methylcellulose (E 464) - 7.80 mg

hydroxypropyl cellulose (E 463) - 1.30 mg, stearic acid (E 570) - 0.91 mg

talc (E 553b) - 1.30 mg

polyethylene glycol - 0.39 mg

titanium dioxide (E171) - 1.30 mg] - 13.00 mg.

Indications

Functional dyspepsia not associated with organic diseases of the gastrointestinal tract

chronic gastritis and gastroduodenitis in the exacerbation phase, including those associated with Helicobacter pylori

peptic ulcer of the stomach and duodenum in the acute phase, including associated with Helicobacter pylori

irritable bowel syndrome, occurring mainly with symptoms of diarrhea.

INN / Active ingredient

Bismuth tripotassium dicitrate

Storage conditions and periods

At a temperature not higher than 25 degrees.

Expiration date: 2 years

Contraindications

Increased individual sensitivity to drug components

-pregnancy

-the period of breastfeeding

- taking medications containing bismuth

-chronic renal failure

- children under 4 years old.

Specifications

Category

Preparations for the gastrointestinal tract

,

Ulcer and gastritis

,

Antacids

Scope of the medicinal product

Gastrointestinal tract

Release form

Tablet

Manufacturer country

Russia

Package quantity, pcs

40

Scope of application

Gastroenterology

Minimum age from

4 years old

Way of introduction

Through the mouth

Vacation conditions

Without recipe

Brand name

OTCPharm

The amount of the dosage form in the primary package

10 pieces.

Primary packaging type

Blister

Type of consumer packaging

Pack of cardboard

Anatomical and therapeutic characteristics

A02BX05 Bismuth tripotassium dicitrate

Dosage form

Film-coated tablets

Expiration date in days

730

Package weight, g

twenty

Mode of application

:

Adults and children over 4 years old - inside 2-4 times / day 30 minutes before meals.

The dose depends on the age of the patient.

< br> The course of treatment is 4-8 weeks.

For the next 8 weeks, do not take bismuth-containing drugs.

< br> For the eradication of Helicobacter pylori, it is advisable to use bismuth tripotassium dicitrate in combination with antibacterial drugs with anti-Helicobacter activity.

Pharmaco-therapeutic group

:

Antiulcer, antiseptic intestinal and astringent

Dosage (volume) of the substance in the preparation

:

bismuth tripotassium dicitrate 303.03 mg, which corresponds to the content of bismuth oxide 120 mg